Company Filing History:
Years Active: 2023-2025
Title: Innovations of Peng Ke in Cardiovascular Treatments
Introduction
Peng Ke is an accomplished inventor based in Cambridge, GB. He has made significant contributions to the field of medical science, particularly in the development of novel therapeutic approaches for cardiovascular diseases. With a total of 2 patents to his name, his work is paving the way for innovative treatments.
Latest Patents
Peng Ke's latest patents focus on heterodimeric Relaxin fusion polypeptides. The first patent describes the invention of heterodimeric Relaxin fusion polypeptides, specifically heterodimeric Relaxin 2 fusion polypeptides, and their various applications. This invention provides Relaxin fusion polypeptides, nucleic acid molecules, vectors, host cells, pharmaceutical compositions, and kits that include these components. The polypeptides and compositions are particularly useful in treating cardiovascular diseases, such as heart failure. The second patent reiterates the same innovations and applications, emphasizing their potential in medical treatments.
Career Highlights
Peng Ke is currently associated with Medimmune Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative therapeutic solutions.
Collaborations
Peng has collaborated with notable colleagues, including Isabelle Sermadiras and Monika Anna Papworth. These collaborations have further enriched his research and contributed to the success of his inventions.
Conclusion
Peng Ke's innovative work in the field of cardiovascular treatments exemplifies the impact of scientific research on healthcare. His patents on heterodimeric Relaxin fusion polypeptides represent a significant advancement in the treatment of heart failure and other cardiovascular diseases.